New medications and treatments for pancreatic cancer must be shown to be safe and effective before doctors can prescribe them to patients. Through pancreatic cancer clinical trials, researchers test the effects of new drugs on a group of volunteers with pancreatic cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat pancreatic cancer, its safety, and any possible side effects.